Re. Re.: “Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation”

Re. Re.: “Immunothrombotic dysregulation in Chagas disease (CD) and COVID-19: a comparative study of anticoagulation”: In the commentary on our paper, Hasslocher-Moreno made the point that indeterminate and digestive forms are not related to thromboembolic events, only thrombogenic alterations occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Campos Mayoral, Laura, Hernández-Huerta, María Teresa, Pérez-Campos Mayoral, Eduardo, Matias Cervantes, Carlos Alberto, Pérez-Campos, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277605/
https://www.ncbi.nlm.nih.gov/pubmed/35829869
http://dx.doi.org/10.1007/s11010-022-04511-3
Descripción
Sumario:Re. Re.: “Immunothrombotic dysregulation in Chagas disease (CD) and COVID-19: a comparative study of anticoagulation”: In the commentary on our paper, Hasslocher-Moreno made the point that indeterminate and digestive forms are not related to thromboembolic events, only thrombogenic alterations occur in CD with cardiopathy, however there is indirect evidence related to thombotic alterations, such as cerebral thrombosis. Our assertion is based on previous data discussed in this letter.

Ejemplares similares